Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the first CRO to completely integrate this technology into its workflows. The ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

The integration of Clinical Data Studio into ICON's service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to ...

The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a ...

A 300-strong South West-based pharmaceutical firm has posted results featuring a surge in turnover and profits.

ICON Public Limited (NASDAQ:ICLR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fifteen ...

Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...

Wasatch Global Select Fund—Investor Class was down -3.90%, underperforming the benchmark MSCI AC (All Country) World Index, ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...

Follow BBC Two and BBC Scotland coverage, live text commentary, score updates and match stats from Scotland v Greece in the ...